 |
Home
Services
Experts
News
Publications
Presentations
Contact DEGGE
_____________________
B.R.I.D.G.E. TO DATASM
PERI Inc.
"Kidz with Leukemia: A Space Adventure"
"Conquering Cancer Network"
|
The Degge Group Ltd (Degge) provides research and regulatory consulting services in pharmacoepidemiology, risk management, clinical drug safety, and pharmacovigilance to the pharmaceutical and medical product sector.
Degge 's staff has contributed to the burgeoning fields of pharmacoepidemiology and pharmacovigilance for over two decades and has worked to enhance the understanding of drug safety, drug use, natural history of disease, pharmacoeconomic and outcomes research, and recently risk evaluation and mitigation strategies (REMS).
Degge will help you identify and analyze key factors and find the right solution.
Announcements:
The Degge Group, Ltd. presented one short course, four posters, one symposium, and one workshop at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Brighton, UK, August 18 - 22, 2010.
FRIDAY, 20 AUGUST
SYMPOSIUM -
3:30 P.M. | Ascertaining the Use of Biologics (Biologics SIG Symposium)
POSTERS:
Accuracy of Reporting and Method for Classifying Progressive Multifocal
Leukoencephalopathy (PML) within the FDA Adverse Event Reporting System (AERS) [108]
Educating a Pharmacoepidemiology Researcher on Selecting Optimal Healthcare Databases for Research [158]
SATURDAY, 21 AUGUST
POSTER:
Validation of a Claims-Based Diagnostic Code for Stevens-Johnson Syndrome (SJS) in a Commercially-Insured Population [463]
SUNDAY, 22 AUGUST
WORKSHOP - 1:30 P.M. | Lessons Learned from Collaboration Among EU Biologics Registries in Rheumatology (Biologics SIG Symposium)
POSTER:
Methodological Challenges in Evaluating Long-Term Safety of Quinacrine Non-Surgical Sterilization [707]
|
The Degge Group, Ltd.
Consulting in
clinical drug safety, pharmacovigilance, and pharmacoepidemiology since 1988.
1616 North Fort Myer Drive, Suite 1430
Arlington, Virginia 22209 USA
Phone: +1 (703) 276-0067 || Fax: +1 (703) 276-0069
|